New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors.
about
Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVSItalian guidelines for primary headaches: 2012 revised versionTEV-48125: a review of a monoclonal CGRP antibody in development for the preventive treatment of migraine.Therapeutic antibodies against CGRP or its receptorCritical role of calcitonin gene-related peptide receptors in cortical spreading depression.Meningeal blood flow is controlled by H2 S-NO crosstalk activating a HNO-TRPA1-CGRP signalling pathway.Trigeminal Pain Molecules, Allodynia, and Photosensitivity Are Pharmacologically and Genetically Modulated in a Model of Traumatic Brain Injury.Cortical spreading depression as a target for anti-migraine agents.Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditionsThe role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine.CGRP and NO in the trigeminal system: mechanisms and role in headache generation.The pipeline in headache therapy.Sumatriptan iontophoretic transdermal system: a review of its use in patients with acute migraine.Insights into the pharmacological targeting of the trigeminocervical complex in the context of treatments of migraine.Emerging targets in migraine.Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity.New treatments for headache.Sumatriptan inhibition of N-type calcium channel mediated signaling in dural CGRP terminal fibres.Evaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptide.BMS-927711 for the acute treatment of migraine.Familial and sporadic hemiplegic migraine: diagnosis and treatment.Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program.Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: Targets and anti-migraine mechanisms.Clinical trials update--2012: year in review--a comment.
P2860
Q27021649-61324D71-B151-47FD-A9B5-8DF01303E908Q30466790-57908628-F85E-4216-B8D2-5AF4E67D401FQ34466377-B9DCBF15-E1EA-4D99-916D-EE588C6511E6Q35684794-D4D35A41-B610-4895-AB22-4850211E39C8Q36414887-386663BF-4B68-4454-906F-3520A20BF2A8Q36506877-4782BAEB-DCE6-4917-A299-8FA5E822BDB2Q36825154-70663695-08EA-4DBD-8286-53590C648FE3Q37056769-29D80A38-78B2-40C5-8BF1-1998C8A898E6Q37492012-3D8B6CB0-8967-43BD-ADA2-AF207CB1C8EDQ37713262-D9EAE5BC-F554-44E5-832C-C2295B21E0E6Q38025661-15185584-181B-42B7-8109-1E75FF9C15B1Q38120491-24A697D6-339E-472C-9044-4BA6325D8141Q38126369-89D86335-8CB0-4F8E-9146-3649B3CAC1BAQ38129436-577674F3-6DDC-4D14-84D1-223790BA3048Q38169593-5CF4E954-71E8-4E7F-8709-77C9CA5C4824Q38196732-D68BCE0E-1441-4FF6-AE3A-CBA26A6E7DBFQ38215470-5FF51495-75B6-4832-8B9A-818A75F8B7A3Q42073244-BDE360CC-B58A-4EC9-BDA0-614593E2AECBQ42120403-F8607CC7-F83D-4229-A58C-1D825B45873CQ45137898-4FB8A4A7-EDC6-4789-B84B-3721CBEE7F66Q46069840-A7FA79AD-AF53-4117-8B73-467738B29C69Q46698001-8D8BE5F4-7181-4B65-AD0B-A2F83A870E0FQ48405754-F929FC43-F425-4270-B618-7F63DD8586AAQ50950442-9D07EFB8-DD21-45BA-B2DA-C2D1AC713C8D
P2860
New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors.
@en
New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors.
@nl
type
label
New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors.
@en
New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors.
@nl
prefLabel
New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors.
@en
New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors.
@nl
P2860
P1476
New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors.
@en
P2093
Jan Hoffmann
P2860
P2888
P356
10.1007/S11940-011-0155-4
P577
2012-02-01T00:00:00Z